SCHEMBL483589

SCHEMBL483589

Cc1c(C)c(C)c2c(c1C)-c1nc-2nc2[nH]c(nc3nc(nc4[nH]c(n1)c1ccccc41)-c1ccccc1-3)c1c(C)c(C)c(C)c(C)c21.[Cu]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.35
THRB P10828 1/20 0.35
APEX1 P27695 1/20 0.35
RECQL P46063 1/20 0.35
BLM P54132 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP1A2 P05177 3/20 0.32
CYP3A4 P08684 3/20 0.32
HSD17B10 Q99714 3/20 0.32
CYP2C19 P33261 2/20 0.32
USP2 O75604 1/20 0.32
CYP2D6 P10635 1/20 0.32
ALOX15 P16050 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32
KDM4E B2RXH2 3/20 0.32
TSHR P16473 2/20 0.32
TOP2A P11388 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3456400 0.99 MEN1 (0.35) MEN1THRBAPEX1RECQLBLM
SCHEMBL9871307 0.97 MEN1 (0.35) MEN1THRBAPEX1RECQLBLM
SCHEMBL2786994 0.94 MEN1 (0.38) MEN1THRBAPEX1RECQLBLM
SCHEMBL813548 0.93 MEN1 (0.38) MEN1THRBAPEX1RECQLBLM
Ciaftalan SCHEMBL9792952 0.93 MEN1 (0.38) MEN1THRBAPEX1RECQLBLM
SCHEMBL8958676 0.84 HSD17B10 (0.40) MEN1KMT2ACYP1A2CYP3A4HSD17B10
SCHEMBL7905277 0.82 MEN1 (0.36) MEN1THRBAPEX1RECQLBLM
SCHEMBL23880594 0.81 MEN1 (0.38) MEN1THRBAPEX1RECQLBLM
Ciaftalan SCHEMBL3246108 0.81 MEN1 (0.45) MEN1THRBAPEX1RECQLBLM
Ciaftalan SCHEMBL38592 0.81 MEN1 (0.45) MEN1THRBAPEX1RECQLBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200388791-A1 ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING CAPPING LAYER AND USE VALIANT CO., LTD. 2020-12-10 US disclosed
US-8841105-B2 Organic-inorganic composite material and process for producing same NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) 2014-09-23 US disclosed
US-20120034670-A1 ORGANIC-INORGANIC COMPOSITE MATERIAL AND PROCESS FOR PRODUCING SAME NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) 2012-02-09 US disclosed
EP-2412677-A1 ORGANIC-INORGANIC COMPOSITE MATERIAL AND PROCESS FOR PRODUCING SAME National University Corporation Okayama University (JP) 2012-02-01 EP disclosed
US-8039040-B2 Method for luminescent layer formation and organic electroluminescent device DAI NIPPON PRINTING CO., LTD. (JP) 2011-10-18 US disclosed
US-20110180826-A1 PRINTING METHOD, METHOD FOR FORMING LIGHT EMITTING LAYER, METHOD FOR FORMING ORGANIC LIGHT EMITTING DEVICE, AND ORGANIC LIGHT EMITTING DEVICE DAI NIPPON PRINTING CO., LTD. (JP) 2011-07-28 US disclosed
US-7986087-B2 Color conversion media and EL-display using the same DAI NIPPON PRINTING CO., LTD. (JP) 2011-07-26 US disclosed
US-20090081480-A1 METHOD FOR LUMINESCENT LAYER FORMATION AND ORGANIC ELECTROLUMINESCENT DEVICE DAI NIPPON PRINTING CO., LTD. (JP) 2009-03-26 US disclosed
US-7329984-B2 Organic EL devices KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2008-02-12 US disclosed
US-20070247066-A1 Electrode Substrate and Its Manufacturing Method IDEMITSU KOSAN CO., LTD. (JP) 2007-10-25 US disclosed
WO-1990014744-A1 ELECTROLUMINESCENT DEVICE WITH SILAZANE-CONTAINING LUMINESCENT ZONE EASTMAN KODAK COMPANY (US) 1990-11-29 WO disclosed
EP-0388768-A2 Organic electroluminescent device containing aromatic dimethylidyne compounds IDEMITSU KOSAN COMPANY LIMITED (JP) 1990-09-26 EP disclosed
US-4950950-A Electroluminescent device with silazane-containing luminescent zone EASTMAN KODAK COMPANY (US) 1990-08-21 US disclosed
EP-0349265-A2 Electroluminescent devices EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1990-01-03 EP disclosed
US-4885211-A CONTAINING MAGNESIUM AND METAL WITH HIGHER WORK FUNCTION; STABILITY EASTMAN KODAK COMPANY (US) 1989-12-05 US disclosed
EP-0281381-A2 Electroluminescent device with modified thin film luminescent zone EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1988-09-07 EP disclosed
US-4769292-A Electroluminescent device with modified thin film luminescent zone EASTMAN KODAK COMPANY (US) 1988-09-06 US disclosed
EP-0278758-A2 Electroluminescent device with organic luminescent medium EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1988-08-17 EP disclosed
EP-0278757-A2 Electroluminescent device with improved cathode EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1988-08-17 EP disclosed
US-4720432-A Electroluminescent device with organic luminescent medium EASTMAN KODAK COMPANY (US) 1988-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120034670-A1 ORGANIC-INORGANIC COMPOSITE MATERIAL AND PROCESS FOR PRODUCING SAME RIOX2, MAOA, FTO MEN1 1020/4885THRB 3040/4885APEX1 2351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.